Description
Basic introduction
Tirzepatide is a synthetic peptide investigated through both GIP and GLP-1 receptor pathways. Its structure includes a lipid modification, which is relevant to the pharmacological preparation described in the scientific literature.
The research spans receptor assays, animal models and clinical studies. These evidence levels should remain separate: a receptor response characterizes one aspect of a molecule, while a clinical study concerns a defined formulation, population and protocol.
Mechanism of action · Research context
GIP receptor response
Tirzepatide was characterized as a GIP receptor agonist. Receptor-specific assays help define this activity independently of its response at the GLP-1 receptor.
GLP-1 receptor response
GLP-1 receptor activity provides a second experimental pathway. Comparing signaling in matched assay systems is more informative than assuming equal activity at both receptors from the dual-agonist label alone.
Integrated metabolic effects
Whole-system responses involve more than receptor activation. The discovery program examined glucose-dependent insulin secretion and metabolic outcomes across several experimental settings.
Extended research considerations
Receptor assay controls
Identify the receptor expression system and readout. Differences in receptor abundance, assay timing or signal amplification can affect comparisons between GIP and GLP-1 responses.
Formulation and exposure
Lipid modification influences the tested preparation. Analytical identity, aggregation and compatibility with the assay medium are separate from the receptor-response result.
Clinical evidence context
Clinical trials evaluate specific pharmaceutical preparations. Their outcomes do not certify the identity, sterility or clinical suitability of a research product sold independently of those studies.
Material and packaging
Available kit specifications: 5 mg × 10 vials; 10 mg × 10 vials; 15 mg × 10 vials; 20 mg × 10 vials; 30 mg × 10 vials; 40 mg × 10 vials; 50 mg × 10 vials; 60 mg × 10 vials; 100 mg × 10 vials; 120 mg × 10 vials. Select an option above to view its current price and availability.
Storage and handling
Source-listed storage condition: Store at 20°C to 25°C (Do not freeze). Follow the handling instructions supplied with the actual batch and your laboratory's procedures.
Analytical documentation
Reference analytical documents are available with this listing. Check the material identity, batch number and test date against the batch supplied; contact us for current batch documentation.
Scientific references
These publications describe the studied molecules and experimental models. They do not certify the identity, quality or effects of a particular supplied batch.
- Discovery and experimental characterization of LY3298176
- Phase 2 tirzepatide clinical research
View report
View report
Clara Montgomery –
Buying the 10-vial bulk pack on sale greatly reduces my lab’s peptide expenditure. My long-term metabolism trials run for months, every new batch retains identical purity and potency. Different vial strengths work for both small screening and large animal trials.
Clayton W. –
This TR10 Tirzepatide is high-quality white lyophilized powder with an acetic acid buffer system. HPLC testing confirmed purity exceeds 99%. The pH remains stable between 4.2–5.2. When stored at 20–25°C without freezing, the long-chain peptide stays intact with no degradation for long-term research use.
Kai Carter –
I have restocked TR10 monthly for 10 consecutive months, and it is my exclusive Tirzepatide research peptide supplier for all metabolism, weight loss and insulin resistance lab projects. Reliable ≥99% HPLC purity standards, easy room-temperature non-freeze storage rules, a full spectrum of flexible vial dosage options, and rock-solid consistent cross-batch potency resolved all erratic, unrepeatable assay data issues I encountered with cheaper generic competing peptide brands.
Emmett Y. –
Perfect for metabolic and weight loss research. The acetic acid buffer protects the peptide structure after reconstitution, so the mixed solution stays clear and stable for multiple days. Every glass vial arrived intact with no breakage or leakage during transit.
Blair Travis –
The built-in acetic acid buffer locks a stable pH of 4.2–5.2, so I skip manual pH calibration when mixing with my standard cell culture media. Sealed unopened vials retain full biological potency for months when kept in dark ambient cabinets, no need for dedicated -20°C freezer space like other research peptides. Every glass vial arrives fully intact with zero breakage or leakage during international cross-border lab shipping.